Edwards Lifesciences Receives FDA Approval for Tricuspid Valve Repair System

Edwards Lifesciences has received FDA approval for its tricuspid valve repair system, enhancing treatment options for patients with structural heart disease. This approval is a significant development for the company's transcatheter heart valve technologies and is expected to bolster its market position in the structural heart sector.